A new adjunct to the treatment and management of depression: intravenous infusion of chlorimipramine (anafranil) by Becker, AL
168 S.-A. MEDIESE TYDSKRIF 13 Februarie 1971
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0;; Oak received: 5 'ovember 1970.
*Many patients, especially on intravenous ch~orimipramine, went to work
after treatment in the morning and were assumed to have haif a day
taken off for each day of treatmenl.
response to therapy, and side-effects. In order to compare
the ECT and chlorimipramine groups patients 'were paired
for sequential analysis according to sex, age (within 5
years) and, wherever possible, severity of symptoms. Data
were scored as indicated in Table 1.
The two psychiatric inpatient units at Johannesburg Hos-
pital together handle about 1000 patients annually. These
units cater to a population of about 600 000 people and
are involved in the investigation, treatment, management
and disposal of patients who are psychiatrically ill as well
as psychiatric emergencies. This service is in addition to
the already extensive outpatient facilities at Johannesburg
Hospital as well as the Tara Neuro-Psychiatric Hospital
for long-term therapy.
Technique of Chlorimipramine Infusion
Initially 1 ampoule of chlorimipramine 25 mg in 250
mg of 5°~ dextrose saline was administered intravenously
at the rate of 60 drops per minute. The duration of the
drip was 1 - 2 hours. With increasing experience and con-
fidence intravenous infusions of 50 - 100 mg were given.
Later, for economy reasons, 25 mg of the drug in 150 ml
dextrose saline was given at 25 - 30 drops per minute.
However, it was found that when larger doses of the
drug were given, particularly 75 - 100 mg, the tendency
to local venous thrombosis increased and the higher doses
were subsequently given in 250 or 500 ml of dextrose
saline. The small vessels of the hand and forearm were
used.
This method of scoring for response to treatment gives
most weight to the number of treatments (a possible 4
out of 9, i.e. 44%) and days off work (a possible 3 out of
9, i.e. 33%). Factors such as side-effects had a low
weighting (2 out of 9, i.e. 22%).
Selection of Cases
Ten criteria of depression were chosen, viz.:
1. Depression including attempted suicide and suicidal
ideas.
2. Psychological and psychomotor retardation, includ-
ing poor concentration and falling-off of work per-
formance.
3. Terminal insomnia.
4. Diurnal variation of mood.
5. Loss of weight.
6. Guilt.
7. Hypochondriasis.
8. Loss of libido and amenorrhoea.
9. Agitation.
10. Previous history.
Only patients who presented 5 or more of these criteria
were considered in the study and at least 2 of the first 5
criteria were present in every case.
RESULTS
From a clinical point of view, the most notable effect of
intravenous chlorimipramine was the rapid response to
treatment. There was an improvement of more than 50""
Associated Therapy
Doses of oral chlorimipramine 25 mg b.d. or t.d.s. were
continued when intravenous therapy had been stopped.
It had been the rule in these units to continue antide-
pressant oral drug therapy on discharge for 3 - 12 months
as outpatients. The follow-up at outpatient level is usually
66 - 75°~ for the first 2 years. In addition to psychotherapy,
especially in the early stages, a minor or major tran-
quillizer or a minor antidepressant was often instituted.
Occupational therapy and adjunct treatments were given
when necessary. For the purpose of this trial, however,
only the intravenous therapy phase was studied and con-
comitant treatment was kept constant as far as possible.
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The aims of the present investigation were to estimate
the effects of intravenous chlorimipramine therapy and
to compare, if possible, the results obtained by electro-
convulsive therapy (BCT). Because of practical difficulties
it was not possible to do a double-blind study comparing
intravenous infusion against electroconvulsive shock. In
addition to the major study, a group of inpatients treated
with conventional antidepressant drugs were compared
with the other two groups.
A total of 438 patients were studied during 1967 - 1970
and the chlorimipramine group were investigated between
June 1968 and May 1970. One group comprised 352
inpatients of whom 58 received ECT (21 males, 37 fe-
males), 255 conventional antidepressant therapy and 39
intravenous chlorimipramine (7 males, 32 females). In
addition, there were 86 outpatients of whom 31 were
treated with ECT (13 males, 18 females) and 55 with
infusion of chlorimipramine (21 males, 34 females).
Ages of patients ranged from under 20 to over 60
years with slightly more cases in the 21 - 30, 41 - 50 and
51 - 60 decades. There were, however, no significant differ-
ences between the two groups.
Parameters studied included the period in hospital and
number of days off work, number of treatments required,
TABLE I. SCORING OF DATA
Number of TreatmelllS needed for improvemenT:
Number of treatments 12+ lO - 12 7 - 9
Score 0 1 2
Days before retum to 1V0rk or off work:
Days before working* 15+ lJ - 15
Score 0 1
Side-effecTs oTher than confusion:
Severe Mild None
Score 0 1 2
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I treatments or within 10 days in which these treat-
were given. The avoidance of anaesthetic and the
~ble post-EeT confusion as well as the readiness
:tivity after the intravenous treatment proved to be
mportant advantages for the new form of therapy.
responsibility of the therapeutic team was to get
ts out of hospital and back to work; after the first
Jtbs of the study approximately 75% of the patients
being treated as outpatients so that there was no
to admit them to hospital and, in addition, they
go back to work on the same day after the infusion
lY·
~ffects of Infusion Therapy
:ating, drowsiness, mild dizziness and sinus tachy-
occurred very commonly, but these effects did not
'b the patients. At least half the patients would
for t - 1 hour after the treatment and for longer
Is with higher doses, and the reactions always
I off without any severe after-effects. Blood pressure
lOt significantly affected in any of the cases. No
ic reactions were noted. In fact, throughout the
the complications were notable by their absence.
pyramidal symptoms occurred in 3 patients, all fe-
, only one of which was severe enough to necessitate
ltinuing treatment; this patient had developed severe
Jyramidal symptoms on all the antidepressive drugs
)usly tried. The two mild cases of parkinsonism
aded easily to antiparkinsonian drugs and treatment
lOt discontinued. Local venous thrombosis occurred
patients, 3 females and 1 male, to the extent that
required hot fomentations and inunction of local
in or hyaluronidase. At no stage did the phlebo-
lbosis require cessation of treatment.
~ case developed congestive cardiac failure and
py was discontinued although it was felt that this
mrelated to the treatment. Nevertheless, in the final
this case was assessed as being a failure with serious
:ffects.
tical Evaluation of Data
;hi-squared test was applied to the data to test if the
ences were significant between the proportion of
ltS in hospital whe improved using the three different
nents, viz. EeT, antidepressant drug and intravenous
lon of chorimipramine. This proved to be so, for
aale and female patients combined, at the 2% level
~nificance.
e central limit theorem was used to test the difference
:he two treatments EeT and intravenous infusion of
imipramine), between the mean numbers of treat-







used to test the difference between the total mean
s. U- calculated will have an approximate normal
one distribution under the nul hypothesis of no
·ence. The difference between the mean number of
nents gave a V-value of 3'92. This is significant (in
favour of chlorirniprcmine) at the 0·01 % level of signifi-
cance (i.e. less than 1 chance in 10000 of obtaining this
result by chance alone).
The average number of treatments for patients having
EeT was 6'67 ± 0'80 whereas the average for patients
on intravenous infusion of chlorimipramine was 4·71 ±
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Fig. 1. Number of treatments with ECT compared with
chlorimipramine therapy.
illustrate these results diagrammatically and the break-
through with regard to the number of treatments occurred
at a preassigned significance level of P = 0·001 (Fig. 1).
The difference between the mean number of days off
work gave a U-value of 11'49. This is a highly significant
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Fig. 2. umber of days off work in patients on ECT
compared with chlorirnipramine therapy.
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fhere is less than 1 chance in 10 000 of obtaining a result
as large as this by chance alone. The average number of
days off work for a patient having EeT was 32 (32·30 ±
1·71), whereas for' chlorimipramine it was only 9 days,
i.e. (8·98 ± 1·10). A roughly linear relationship was found
between the number of treatments for patients on ECT
and the number of days off work. This is not true when
a patient is on chlorimipramine where the maximum
number of days off work was 30. This may not, however,
be due to the effect of treatment, but rather to the method
of application. A sequential control chart again showed
TOTAL SCORES
50
a breakthrough at a preassigned significance level of
p = 0·001 in favour of chlorimipramine (Fig. 2).
This mean difference between the total scores was sig-
nificant at the 1% level of significance in favour of
chlorimipramine (Fig. 3).
The equations of the lines for sequential analyses used
were:
Y, -8'5168 + 0·4997X
Y, +8'5168 + 0·4997X
for X = 0 Y, -8·5168 Y, = + 8·5168
]7 0
30 6·5
60 21·5 = 38·5
No of pairs














The difference between the proportion of patients in hospital
who improved when treated with electroconvulsive therapv.
conventional antidepressant drug therapy and intravenous in·
fusion of chlorimipramine was statistically significant in favour
of the last-mentioned treatment. Patients on chlorimipramine
as a group needed fewer treatments and returiled to work
more rapidly than did their counterparts having electrocon·
vulsive therapy. There were no side-effects other than con·
fusion in patients having electroconvulsive therapy while several
on the infusion suffered from mild side-effects. One patient
developed congestive cardiac failure. This was thought to be
due to other causes but was assessed as being due to the
infusion.
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HislOcornpatibililY Testing 1970. Ed. by P. I. Terasaki. Pp.
658. Illustrated. Dan. Kr. 148,50. Copenhagen: Munksgaard.
1970.
This is a comprehensive report (658 pages) on the January
1970 International Workshop and Conference on Histocom-
patibility Testing held in Palm Springs and Los Angeles. Every
aspect of the subject is extensively dealt with, including the
genetics and serology of the HL-A system, histocompatibility
testing in clinical transplantation, the chemical characterization
of the HL-A antigens, and an excellent section on serological
and immunological techniques. This is the most extensive and
up-to-date work in this field currently available.
THORACIC CARE
Chest Tubes and Chest Bollles. By A. von Hippel, M.D.,
F.A.C.S., FI.C.S. Pp. xv + 96. $7.00. Springfield, Ill.:
Charles C. Thomas. 1969.
One is frequently approached, especially by colleagues in
outlying districts, on the use of intrapleural drainage tubes.
It seems that few doctors, even students of thoracic surgery,
let alone nurses, understand the 'mysteries' of chest tubes and
chest bottles. _
The author of this monograph has been most successful in
presenting all the facets of sealed pleural drainage in a clearly
illustrated, simple but concise way which makes tbe reading
pleasant and most informative.
This manual is a truly worth-while guide for all tbose con-
cerned with thoracic care. J.C.v.d.S.
BOEKBESPREKINGS
ATLAS VAN DWARSSNITTE
A Cross-Section Anatomy. Deur A. C. Eycleshymer, B.S.,
Ph.D., M.D. en D. M. Schoemaker, B.S., M.D. Pp. xvi +
215. GeIllustreer. R32.00. Londen en Durban: Butterworth.
1970.
Dit is 'n atlas en handleiding van makroskopiese dwarssnitte
deur die menslike liggaam. Die eerste uitgawe het in 1911
verskyn en die huidige is 'n historiese heruitgawe van hierdie
klassieke werk met die oorspronklike illustrasies voortreflik
gedoen deur Tom Jones. In die eerste hoofstuk word die
historiese agtergrond, doelstelling, materiaal en metodes be-
spreek. Die regionale dwarssnitte, kop en nek, toraks, abdomen,
bekken, ingeslote vroulike bekken en 1edemate word toegelig
met bygaande verklarings in hoofstuk twee. Die derde hoofstuk
word gewy aan die topografie van organe. Daar word ook 'n




Liver Disease. By A. Paton, M.D., F.R.C.P. Pp. vii + 185.
lllustrated. £1.10.0. London: William Heinemann Medical
Books. 1970.
This book sets out to present liver disease in a succinct but
relatively superficial manner. Unfortunately its very abbrevia-
tion makes it of limited value. It has the defect of merely
whetting the appetite while supplymg nothing like enough
information to give the student a real appreciation of tbe
clinical problems in liver disease. Certain important areas are
treated far too sup~rficially. S.J.S.
